Mammaglobin: A novel tumor marker for breast cancer

Turkish Journal of Cancer

Volumn 37, Issue 3, 2007, Pages 89-97

  El Sharkawy, Sonia Labib ^a   El Aal, Wafaa El Saied Abd ^a   El Shaer, Marwa Abd El Monaem ^a   Abbas, Naglaa Fathy ^a   Youssef, Mona Fathy ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Breast carcinoma; Estrogen receptor; Immunohistochemistry; Ki 67; Mammaglobin; PCR

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; MAMMAGLOBIN; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER LOCALIZATION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION;

EID: 37249012843     PISSN: 10193103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Leygne E, Snell L, Dotzlow H. Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol 1999;189:28-33.
2. McPherson K, Steel CM, Dixon JM. ABC of breast diseases: Breast cancer epidemiology, risk factors and genetics. Br Med J 2000;321:624-8.
3. Gargano G, Agnese V, Calo V, et al. Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. Ann Oncol 2006;17 Suppl 7:vii41-5.
4. Gilbey AM, Burnell D, Coleman RE, et al. The detection of circulating breast cancer cells in blood. J Clin Pathol 2004;57:903-11.
5. Grunewald K, Haun M, Fiegl M. Mammaglobin expression in gynecologic malignancies. Lab Invest 2002;82:1147-53.
6. Miele L, Miele EC, Mantile G. Uteroglobin and uteroglobin-like proteins: The uteroglobin family of proteins. J Endocrinol Invest;17:679-92.
7. Bloom HJG, Richardson WW. Histopathological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-77.
8. Wilson RE. The Breast. In: Sabiston DC, editor. Textbook of Surgery: The biologic basis of modern surgical practice. 13th ed. London, Philadelphia, Toronto: W.B. Saunders Co. Ltd, 1986;530-72.
9. Han J, Kang Y, Shin H, et al. Mammaglobin expression in lymph node is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med 2003;127:1330-4.
10. Eerola H, Heikkila P, Tamminen A, et al. Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families. Breast Cancer Res 2005;7:R93-100.
11. Jiang WG, Martin TA, Mansel RE. Molecular detection of micrometastasis in breast cancer. Crit Rev Oncol Hematol 2002;43:13-31.
12. Bernstein JL, Godbold JH, Raptis G, et al. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res 2005;11:6528-35.
13. Watson MA, Darrow C, Zimonjic DB. Structure and transcriptional regulation of the human mammaglobin gene. Oncogen 1999;16:817-24.
14. Fleming TP, Watson MA. Mammaglobin, a breast-specific gene and its utility as a marker for breast cancer. Ann N Y Acad Sci 2000;923:78-89.
15. Shira G, Carrie F, Dennis LY, et al. Detection of mammaglobin m-RNA in the plasma of breast cancer patients. Ann N Y Acad Sci 2001;945:192-4.
16. Silva JM, Dominguez G, Silva J. Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics. Clin Cancer Res2001;7:2821-5.
17. Umekita Y, Oki Y, Sagara Y, et al. Coexpression of epidermal growth factor receptor and transforming growth factor alpha predict worse prognosis in breast cancer patients. Int J Cancer 2000;89:484-7.
18. Ma L, De Roquancourt A, Bertheau P, et al. Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocrine and stromal-epithelial interactions. J Pathol 2001;194:413-9.
19. Lee H, Douglas-Jones AG, Morgan JM, et al. The effect of fixation and processing on the sensitivity of estrogen receptor assay by immunohistochemistry in breast carcinoma. J Clin Pathol 2002;55:236-8.
20. Span PN, Waanders E, Manders P. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol 2004;22:691-8.
21. Woosley JT. Measuring cell proliferation. Arch Pathol Lab Med 1991;115:555-7.
22. Nakanishi K, Kawai T, Suzuki M, et al. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts. Hum Pathol 1996;27:240-7.
23. Shina H, Igawa M, Nagami H. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm 23 protein and nuclear DNA content in transitional cell carcinoma of the bladder. Cancer 1996;15:1962-74.
24. Canzonieri V, Monfardini S, Carbone A. Defining prognostic factors in malignancies through image analysis. Eur J Cancer 1998;34:451-8.